PLX - Protalix BioTherapeutics Sales Growth YoY (TTM)

Brandmark of Protalix BioTherapeutics (PLX)

Stable demand for unique therapies for rare pathologies ensures revenue predictability for Protalix BioTherapeutics (PLX). Looking at the annual sales growth rate over a 12-month period on GURU.Markets, the current figure stands at 37.00. Growth is supported by alliances with pharma behemoths via the ProCellEx system, while an asset-light model featuring royalties from biologics effectively scales business margins.

PLX - Protalix Sales Growth YoY (Last Twelve Months) over the range 02/11/2024 - 11/15/2026

Summary analytical data breakdowns for Protalix BioTherapeutics (PLX)

- stock quotes and analyst forecast:
Price Performance Chart Protalix|PLX - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Protalix BioTherapeutics Inc.|PLX - Total Company Value
- book value of equity indicators:
Accounting Value of a Share Protalix BioTherapeutics|PLX - Company Book Value|Market Cap to Net Assets Ratio protalix.com|PLX - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Capital Protalix BioTherapeutics|PLX - Long-Term Debt to Equity|Current Liabilities to Equity Protalix BioTherapeutics Inc.|PLX - Company Debts|Debt to Net Assets Ratio Protalix BioTherapeutics Inc.|PLX - Company Long-Term Debt|Short-Term Debt Protalix BioTherapeutics|Intermediate Liquidity Ratio protalix.com
- earnings and market ratios statistics:
PLX - Net Profit|Projected Future Earnings Protalix BioTherapeutics|PLX - Price to Earnings Ratio|Future Price to Earnings Protalix BioTherapeutics|PLX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Protalix|PLX - Operating profit before deduction of amortization|Earnings per share for the last 12 months Protalix BioTherapeutics|PLX - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months protalix.com|PLX - Earnings growth in current year|Net earnings per share growth forecast for next year Protalix BioTherapeutics
- sales and revenue data:
PLX - Revenue and Sales Volume|Company Future Sales Protalix BioTherapeutics, Inc|PLX - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio Protalix|PLX - Revenue Growth YoY (Last 12 Months)
Analysis of all company metrics:Protalix BioTherapeutics, Inc
Original product of Protalix BioTherapeutics, Inc

Protalix BioTherapeutics' sustainable approach to developing plant-cell-based drugs determines the scaling potential of its commercial operations. By analyzing the historical year-over-year revenue growth trend over the last 12 months, an investor can see the percentage change in current total income relative to the same period last year, which allows for the differentiation of the business maturity stage and an assessment of the company's expansion sustainability.

Competitors of Protalix BioTherapeutics (PLX)

VRTX (Vertex Pharmaceuticals Inc.) - Trailing Twelve Months Sales Growth|Alnylam Pharmaceuticals - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) INSM (Insmed Incorporated)|UTHR: Sales Growth YoY (TTM)|BioMarin Pharmaceutical Inc. (BMRN) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) BridgeBio Pharma Inc|Revenue Growth YoY (Last 12 Months) BGM Group Ltd (BGM)|Sales Growth YoY (Last Twelve Months) cogentbio.com (COGT)|Revenue Growth YoY (Last 12 Months) Xeris Biopharma XERS|Sales Growth YoY (TTM) KROS (kerostx.com)|Sales Growth YoY (TTM) Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Sales Growth YoY (TTM)|KMDA - Sales Growth YoY (TTM)|FULC (Fulcrum Corp) - Revenue Growth YoY (Last 12 Months)|ABEO (Abeona Therapeutics, Inc.) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) mereobiopharma.com|Pliant Therapeutics (PLRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Applied Therapeutics (APLT)|Rein Therapeutics Inc - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) GELS (Gelteq)|Revenue Dynamics YoY (Last Twelve Months) AYTU|CMMB - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth srxhealth.com|PLRZ (Polyrizon) - Revenue Growth YoY (Last 12 Months)|Aeterna Zentaris (AEZS) - Sales Growth YoY (TTM)|CYTH (Cyclo Therapeutics) - Sales Growth YoY (TTM)|INZY: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) RPHM|CSCI (COSCIENS Biopharma) - Revenue Dynamics YoY (Last Twelve Months)